bpc 157 nih BPC-157 Peptide Therapy Christopher Mendias, PhD, gets four

DSIP is a peptide studied in controlled research environments as a model compound in investigations involving peptide structure, signalling pathways, and experimental biological systems

Administration: B12/MIC injections are typically administered intramuscularly twice a week or as directed by your healthcare provider

The BPC-157 Layer: Addresses the structural side (protecting the gut lining from the GI distress GLP-1s often cause, and potentially mitigating the severe muscle loss that accompanies rapid weight reduction)

Understanding injectable versus oral peptide differences also helps contextualize why reconstitution skills matter for the injectable route specifically